140 related articles for article (PubMed ID: 38577372)
1. Integrative chemoproteomics reveals anticancer mechanisms of silver(i) targeting the proteasome regulatory complex.
Shao X; Xing F; Zhang Y; Lok CN; Che CM
Chem Sci; 2024 Apr; 15(14):5349-5359. PubMed ID: 38577372
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells.
Chen X; Yang Q; Chen J; Zhang P; Huang Q; Zhang X; Yang L; Xu D; Zhao C; Wang X; Liu J
Cell Physiol Biochem; 2018; 49(2):780-797. PubMed ID: 30165348
[TBL] [Abstract][Full Text] [Related]
3. Targeting Ubiquitin-Proteasome System With Copper Complexes for Cancer Therapy.
Chen X; Dou QP; Liu J; Tang D
Front Mol Biosci; 2021; 8():649151. PubMed ID: 33928122
[TBL] [Abstract][Full Text] [Related]
4. Structural and spectroscopic studies of some adducts of silver(I) halides with thiourea and N-ethyl substituted thioureas.
Bowmaker GA; Pakawatchai C; Saithong S; Skelton BW; White AH
Dalton Trans; 2010 May; 39(18):4391-404. PubMed ID: 20422096
[TBL] [Abstract][Full Text] [Related]
5. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
[TBL] [Abstract][Full Text] [Related]
6. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.
Chen X; Zhang X; Chen J; Yang Q; Yang L; Xu D; Zhang P; Wang X; Liu J
Eur J Pharmacol; 2017 Nov; 815():147-155. PubMed ID: 28887042
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Proteomics Reveals Extensive Changes in the Ubiquitinome after Perturbation of the Proteasome by Targeted dsRNA-Mediated Subunit Knockdown in Drosophila.
Sap KA; Bezstarosti K; Dekkers DHW; Voets O; Demmers JAA
J Proteome Res; 2017 Aug; 16(8):2848-2862. PubMed ID: 28665616
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-κB inhibition and p53 reactivation in human lung cancer cells.
Zhou B; Zuo Y; Li B; Wang H; Liu H; Wang X; Qiu X; Hu Y; Wen S; Du J; Bu X
Mol Cancer Ther; 2013 Aug; 12(8):1381-92. PubMed ID: 23696216
[TBL] [Abstract][Full Text] [Related]
10. A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.
Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Dou QP; Wang X; Liu J
Oncogene; 2016 Nov; 35(45):5916-5927. PubMed ID: 27086925
[TBL] [Abstract][Full Text] [Related]
11. The 26S proteasome: a molecular machine designed for controlled proteolysis.
Voges D; Zwickl P; Baumeister W
Annu Rev Biochem; 1999; 68():1015-68. PubMed ID: 10872471
[TBL] [Abstract][Full Text] [Related]
12. Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.
Yang H; Chen X; Li K; Cheaito H; Yang Q; Wu G; Liu J; Dou QP
Semin Cancer Biol; 2021 Jan; 68():105-122. PubMed ID: 31883910
[TBL] [Abstract][Full Text] [Related]
13. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.
Grover A; Shandilya A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S15. PubMed ID: 21143798
[TBL] [Abstract][Full Text] [Related]
14. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
[TBL] [Abstract][Full Text] [Related]
15. Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.
Momtaz S; Memariani Z; El-Senduny FF; Sanadgol N; Golab F; Katebi M; Abdolghaffari AH; Farzaei MH; Abdollahi M
Front Physiol; 2020; 11():361. PubMed ID: 32411012
[TBL] [Abstract][Full Text] [Related]
16. Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy.
Frezza M; Schmitt S; Dou QP
Curr Top Med Chem; 2011 Dec; 11(23):2888-905. PubMed ID: 21824109
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System.
Cirri D; Schirmeister T; Seo EJ; Efferth T; Massai L; Messori L; Micale N
Molecules; 2020 Sep; 25(19):. PubMed ID: 32998355
[TBL] [Abstract][Full Text] [Related]
18. Chemical Proteomics Reveals that the Anticancer Drug Everolimus Affects the Ubiquitin-Proteasome System.
Lobas AA; Saei AA; Lyu H; Zubarev RA; Gorshkov MV
ACS Pharmacol Transl Sci; 2024 Mar; 7(3):787-796. PubMed ID: 38481686
[TBL] [Abstract][Full Text] [Related]
19. Involvement of ALAD-20S Proteasome Complexes in Ubiquitination and Acetylation of Proteasomal α2 Subunits.
Schmitt SM; Neslund-Dudas C; Shen M; Cui C; Mitra B; Dou QP
J Cell Biochem; 2016 Jan; 117(1):144-51. PubMed ID: 26084403
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
